Icosabutate

Overview

Icosabutate is under investigation in clinical trial NCT02373176 ([14C] Icosabutate -A Phase I Absorption, Metabolism and Excretion Study).

Icosabutate is under investigation in clinical trial NCT02373176 ([14C] Icosabutate -A Phase I Absorption, Metabolism and Excretion Study).

No indication information available.

No associated conditions information available.

Title	Posted	Study ID	Phase	Status	Sponsor
A Phase 2b Study of Icosabutate in Fatty Liver Disease	2019/08/09	NCT04052516	Phase 2	Completed	NorthSea Therapeutics B.V.
Icosabutate - A Phase I, Single Oral Dose, Safety, Tolerability and Pharmacokinetic Study in Healthy Subjects	2015/02/18	NCT02364635	Phase 1	Completed	Pronova BioPharma
Efficacy and Safety of PRC-4016 in Subjects With Mixed Dyslipidemia	2013/10/30	NCT01972178	Phase 2	Terminated	Pronova BioPharma
The Efficacy and Safety of PRC-4016 in Hypertriglyceridemic Subjects	2013/07/09	NCT01893515	Phase 2	Completed	Pronova BioPharma

Approved Product	Manufacturer	NDC Code	Route	Strength	Effective Date
No FDA approvals found for this drug.

Approved Product	Authorization Holder	Status	Issued Date
No EMA approvals found for this drug.

Approved Product	Manufacturer	Approval Number	Dosage Form	Strength	Approval Date
No HSA approvals found for this drug.

Approved Product	Company	Approval Number	Drug Type	Dosage Form	Approval Date
No NMPA approvals found for this drug.

Approved Product	Registration No.	Company	Licence No.	Strength	Registration Date
No PPB approvals found for this drug.

Approved Product	ARTG ID	Sponsor	Registration Type	Status	Registration Date
No TGA approvals found for this drug.